Ignite Creation Date:
2024-05-05 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00432120
Status:
COMPLETED
Last Update Posted:
2008-01-29
First Post:
2007-02-05
Brief Title:
Clopidogrel Only Before Percutaneous Coronary Intervention or Before Every Coronarography
Sponsor:
Charles University Czech Republic
Organization:
Charles University Czech Republic
Study Overview
Official Title:
Clopidogrel Loading Dose for ad-Hoc Percutaneous Coronary Intervention Immediately Following Elective Coronary Angiography Randomized Multicenter Trial Comparing Pre-Treatment 6 Hours Before Every Angiography vs Cath-Lab Administration After Angiography Just Before Intervention the PRAGUE-8 Trial
Status:
COMPLETED
Status Verified Date:
2007-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Clopidogrel pre-treatment before planned percutaneous coronary intervention was proved to reduce periprocedural complications However the vast majority of patients in the current interventional cardiology practice do not undergo planned PCI but rather ad-hoc PCI performed immediately after coronary angiography Whether clopidogrel should be administered as pre-treatment to all patients undergoing elective CAG with the aim to ensure therapeutic levels at the time of possible ad-hoc PCI is not known
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None